TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33066944

Group type: EXPERIMENTAL
Intervention: Botulinum toxin therapy in combination with dynamic electric neurostimulation and basic therapy
Number of subjects: 96

Group type: COMPARATOR
Intervention: Botulinum toxin therapy and basic therapy
Number of subjects: 96

Group type: COMPARATOR
Intervention: Dynamic electric neurostimulation and basic therapy
Number of subjects: 96

Group type: COMPARATOR
Intervention: Basic therapy only
Number of subjects: 96
Study: 35654457

Group type: EXPERIMENTAL
Intervention: tofacitinib 5 mg twice daily
Number of subjects: 269

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 269
Study: 36329128

Group type: EXPERIMENTAL
Intervention: Topical silicone gel
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Pressure garment
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Combined pressure garment and topical silicone gel therapy
Number of subjects: 153
Study: 32406524

Group type: EXPERIMENTAL
Intervention: Birth of a child with a major congenital anomaly
Number of subjects: 19220
Study: 36461619

Group type: EXPERIMENTAL
Intervention: THRIVE (100% oxygen, 40 L/min)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Facemask pre-oxygenation (100% oxygen, 6 L/min)
Number of subjects: 40
Study: 33351781

Group type: EXPERIMENTAL
Intervention: Alefacept (LFA3‐Ig)
Number of subjects: 0
Study: 32204919

Group type: EXPERIMENTAL
Intervention: General anesthesia with caudal block
Number of subjects: 60

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 60
Study: 35428025

Group type: EXPERIMENTAL
Intervention: Toripalimab plus gemcitabine plus cisplatin (GP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Camrelizumab plus gemcitabine plus cisplatin (GP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gemcitabine plus cisplatin (GP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Toripalimab plus GP
Number of subjects: 0
Study: 34506606

Group type: EXPERIMENTAL
Intervention: Oscillating protein diet (OP, 125 and 173 g/kg CP diets oscillated at 2‐d intervals)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Static protein diet (SP, 149 g/kg CP)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Oscillating protein diet (OP) during the low protein phase
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Oscillating protein diet (OP)
Number of subjects: 12
Study: 35718834

Group type: EXPERIMENTAL
Intervention: Vestibular extraction technique
Number of subjects: 30
Study: 33273376

Group type: EXPERIMENTAL
Intervention: 3D-QALAS with Compressed Sensing (CS)
Number of subjects: 22

Group type: COMPARATOR
Intervention: 3D-QALAS without Compressed Sensing (CS)
Number of subjects: 22
Study: 32791692

Group type: EXPERIMENTAL
Intervention: Intranasal phototherapy for 20 minutes, 3 times a week for 4 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Acupuncture for 20 minutes, 3 times a week for 4 weeks
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Intranasal phototherapy
Number of subjects: 80
Study: 32711440

Group type: EXPERIMENTAL
Intervention: Oral glutamine (400 mg/kg body weight per day)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Oral glutamine
Number of subjects: 24
Study: 33938492

Group type: EXPERIMENTAL
Intervention: Robotic-assisted lobectomy (RAL)
Number of subjects: 320
Study: 34747036

Group type: EXPERIMENTAL
Intervention: Trials reporting suitable baseline data
Number of subjects: 1449

Group type: COMPARATOR
Intervention: Trials with over-representation of very small p-values
Number of subjects: 1449

Group type: COMPARATOR
Intervention: Non-registered trials, studies supported by non-industry funding, and multi-centre RCTs
Number of subjects: 1449
Study: 34544820

Group type: EXPERIMENTAL
Intervention: Ofatumumab (1.50 mg/1.73 m2)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Rituximab (375 mg/m2)
Number of subjects: 140
Study: 32093528

Group type: EXPERIMENTAL
Intervention: Lecture-based empathy enhancement program
Number of subjects: 104

Group type: COMPARATOR
Intervention: Simulation-based empathy enhancement program
Number of subjects: 104
Study: 32273029

Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 32877

Group type: EXPERIMENTAL
Intervention: Female sex
Number of subjects: 32877
Study: 35083878

Group type: EXPERIMENTAL
Intervention: Isometric exercise training (IET) group
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 30

Group type: COMPARATOR
Intervention: No-intervention control group
Number of subjects: 30
Study: 33731070

Group type: EXPERIMENTAL
Intervention: Extended field of view ultrasound imaging
Number of subjects: 26
Study: 32659247

Group type: EXPERIMENTAL
Intervention: Mindful raisin-eating
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Mindful breathing
Number of subjects: 71

Group type: COMPARATOR
Intervention: Non-mindful control task
Number of subjects: 71
Study: 35293122

Group type: EXPERIMENTAL
Intervention: Continuous locking with Steri-Strip (CS group)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Simple interrupted suture (SI group)
Number of subjects: 104
Study: 33121452

Group type: EXPERIMENTAL
Intervention: High dose clopidogrel (150 mg per day) + aspirin (100 mg per day) over 21 days
Number of subjects: 131

Group type: COMPARATOR
Intervention: Normal dose clopidogrel (75 mg per day) + aspirin (100 mg per day) over 21 days
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: High dose clopidogrel + aspirin
Number of subjects: 131

Group type: COMPARATOR
Intervention: Normal dose clopidogrel + aspirin
Number of subjects: 131
Study: 36223114

Group type: EXPERIMENTAL
Intervention: iTBS plus D‐cycloserine (100 mg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: iTBS plus placebo
Number of subjects: 50
Study: 36376812

Group type: EXPERIMENTAL
Intervention: Smoke-free home intervention (face-to-face counseling and instruction)
Number of subjects: 400

Group type: COMPARATOR
Intervention: N/A (control group is wait-list)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: N/A (for PSH staff)
Number of subjects: 400
Study: 32441467

Group type: EXPERIMENTAL
Intervention: Moist Exposed Burn Ointment (MEBO)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Chlortetracycline hydrochloride ointment (Control)
Number of subjects: 61
Study: 34865892

Group type: EXPERIMENTAL
Intervention: In-clinic individual counseling
Number of subjects: 1407

Group type: EXPERIMENTAL
Intervention: In-clinic group counseling
Number of subjects: 1407

Group type: COMPARATOR
Intervention: Phone group counseling
Number of subjects: 1407
Study: 33744088

Group type: EXPERIMENTAL
Intervention: Riociguat
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 65
Study: 34870364

Group type: EXPERIMENTAL
Intervention: Mobile-bearing unicompartmental knee arthroplasty (MB UKA)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Fixed-bearing unicompartmental knee arthroplasty (FB UKA)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Total knee arthroplasty (TKA)
Number of subjects: 180
Study: 36219809

Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 882

Group type: EXPERIMENTAL
Intervention: Pembrolizumab-chemotherapy
Number of subjects: 882

Group type: EXPERIMENTAL
Intervention: Second-course pembrolizumab
Number of subjects: 882

Group type: COMPARATOR
Intervention: Cetuximab-chemotherapy
Number of subjects: 882
Study: 33654192

Group type: EXPERIMENTAL
Intervention: Genomics ADvISER (digital decision aid)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Standard counseling
Number of subjects: 52
Study: 32569355

Group type: EXPERIMENTAL
Intervention: Initiation of ART in the hospital
Number of subjects: 801

Group type: COMPARATOR
Intervention: Participants recruited in Southern hospitals
Number of subjects: 801
Study: 35807149

Group type: EXPERIMENTAL
Intervention: Bloodletting
Number of subjects: 33

Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Combined Oral Contraceptives (COC)
Number of subjects: 33
Study: 32473563

Group type: EXPERIMENTAL
Intervention: Exercise program (12-week, 3 sessions/week) including resistance, endurance, Pilates, balance, and stretch exercises
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Exercise program
Number of subjects: 94
Study: 36346817

Group type: EXPERIMENTAL
Intervention: Positive Written Disclosure (PWD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neutral writing
Number of subjects: 0

Group type: COMPARATOR
Intervention: No writing
Number of subjects: 0
Study: 32717127

Group type: EXPERIMENTAL
Intervention: Structured teaching module including intensive prophylactic measures administered by a trained oncology nurse
Number of subjects: 280

Group type: COMPARATOR
Intervention: Standard information on HFS care administered by treating clinician (control)
Number of subjects: 280
Study: 34935407

Group type: EXPERIMENTAL
Intervention: Dabigatran 110 mg
Number of subjects: 27494

Group type: EXPERIMENTAL
Intervention: Dabigatran 150 mg
Number of subjects: 27494

Group type: COMPARATOR
Intervention: Intensive blood pressure lowering
Number of subjects: 27494

Group type: COMPARATOR
Intervention: Dabigatran vs Warfarin
Number of subjects: 27494
Study: 34460844

Group type: EXPERIMENTAL
Intervention: Bayesian model with shrinkage effect
Number of subjects: 20

Group type: COMPARATOR
Intervention: Bayesian model with non-shrinkage prior
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Bayesian method with maximum entropy prior
Number of subjects: 20

Group type: COMPARATOR
Intervention: Model assuming non-informative priors for multiplicative parameters
Number of subjects: 20
Study: 34953525

Group type: EXPERIMENTAL
Intervention: Combination therapy (abiraterone acetate 1000 mg daily + prednisolone 5 mg daily)
Number of subjects: 1974

Group type: EXPERIMENTAL
Intervention: Combination therapy (abiraterone acetate + prednisolone + enzalutamide 160 mg daily)
Number of subjects: 1974

Group type: EXPERIMENTAL
Intervention: Combination therapy (abiraterone acetate + prednisolone)
Number of subjects: 1974

Group type: COMPARATOR
Intervention: ADT alone (control group)
Number of subjects: 1974
Study: 34478577

Group type: EXPERIMENTAL
Intervention: Low-dose anfibatide (2 IU/60 kg)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Moderate-dose anfibatide (3 IU/60 kg)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: High-dose anfibatide (5 IU/60 kg)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: All anfibatide groups
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 90
Study: 33315342

Group type: EXPERIMENTAL
Intervention: Slow tempo (5/0/3/0) barbell squat
Number of subjects: 10

Group type: COMPARATOR
Intervention: Medium tempo (2/0/2/0) barbell squat
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Both exercise protocols (SLO and MED)
Number of subjects: 10
Study: 36357595

Group type: EXPERIMENTAL
Intervention: Outreach intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 33407774

Group type: EXPERIMENTAL
Intervention: Intravenous methylprednisolone (40 mg)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study: 33913784

Group type: EXPERIMENTAL
Intervention: Cool Little Kids parenting programme
Number of subjects: 27
Study: 34176383

Group type: EXPERIMENTAL
Intervention: Additional real-world evidence (RWE) at product launch
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomized controlled trial evidence (RCTE)
Number of subjects: 0
Study: 33228623

Group type: EXPERIMENTAL
Intervention: Healthcare financing characteristics
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Physician compensation tied to relative value units
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Grant-based services
Number of subjects: 51
Study: 35469070

Group type: EXPERIMENTAL
Intervention: Nurse navigator‐led follow‐up system and web portal-smartphone application on top of usual care
Number of subjects: 559
Study: 33652129

Group type: EXPERIMENTAL
Intervention: Blinded acetaminophen
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Blinded ibuprofen
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control (OTC medications)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Overall adherence
Number of subjects: 300
Study: 34877813

Group type: EXPERIMENTAL
Intervention: Edoxaban 60 mg
Number of subjects: 607

Group type: COMPARATOR
Intervention: Edoxaban 75 mg
Number of subjects: 607
Study: 32132590

Group type: EXPERIMENTAL
Intervention: Predictive weight centile lines based on mixed modelling methods
Number of subjects: 1510

Group type: EXPERIMENTAL
Intervention: New predictive weight centile lines
Number of subjects: 1510

Group type: COMPARATOR
Intervention: UK1990 centile lines
Number of subjects: 1510
Study: 36602066

Group type: EXPERIMENTAL
Intervention: NMCur-aPDT
Number of subjects: 48

Group type: COMPARATOR
Intervention: LED
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: VITIS®
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: NMCur
Number of subjects: 48
Study: 37794320

Group type: EXPERIMENTAL
Intervention: 10-week individualized motor-cognitive eHealth training with cognitive behavioral elements
Number of subjects: 120

Group type: COMPARATOR
Intervention: Active control group (individualized 10-week paper-based home exercise program)
Number of subjects: 120
Study: 32962685

Group type: EXPERIMENTAL
Intervention: Nutrition education (NE) program on pulse-cereal complementary food for mothers delivered by Health Extension Workers (HEWs) for 9 months
Number of subjects: 772

Group type: EXPERIMENTAL
Intervention: Nutrition education (NE) program on pulse-cereal complementary food for mothers
Number of subjects: 772

Group type: COMPARATOR
Intervention: Control group receiving routine health education for 9 months
Number of subjects: 772
Study: 32991345

Group type: EXPERIMENTAL
Intervention: 10-min ball-tapping exercise
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 10-min jogging exercise
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 21
Study: 32249091

Group type: EXPERIMENTAL
Intervention: Integrated securement dressing (ISD) + sterile foam (SF)
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Tissue adhesive (TA) + non-sterile foam (NSF)
Number of subjects: 330

Group type: COMPARATOR
Intervention: Bordered polyurethane dressing (BPU) + non-sterile foam (NSF)
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: No infection at baseline
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Insertion by vascular access specialist
Number of subjects: 330
Study: 36942119

Group type: EXPERIMENTAL
Intervention: Anterograde technique
Number of subjects: 220
Study: 32585079

Group type: EXPERIMENTAL
Intervention: Cysteamine 5% cream
Number of subjects: 50

Group type: COMPARATOR
Intervention: Modified Kligman's formula (MKF)
Number of subjects: 50
Study: 32207274

Group type: EXPERIMENTAL
Intervention: Insulin detemir administered according to the 3-0-3 titration algorithm (G3)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Insulin detemir administered according to the 2-4-6-8 titration algorithm (G2)
Number of subjects: 46
Study: 33301990

Group type: EXPERIMENTAL
Intervention: MOCHA Standard intervention (10-week program including small group discussions, health topic classes, and 60-min aerobic exercise twice a week)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MOCHA+ Stories Matter program (enhanced intervention using narrative communication strategies)
Number of subjects: 0
Study: 32147440

Group type: EXPERIMENTAL
Intervention: Aggressive local treatment (surgery) for oligometastatic disease in gastric cancer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Current ongoing randomized clinical studies
Number of subjects: 0
Study: 36090495

Group type: COMPARATOR
Intervention: S‐HD
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: C‐HD
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: HV‐HDF
Number of subjects: 40
Study: 33343579

Group type: COMPARATOR
Intervention: HLA-A*02:05, B*58:01, C*07:01, DRB1*03:01 haplotype
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: HLA-C*04:01 allele and HLA-A*30:02, B*14:02, C*08:02 haplotype
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: HLA-DRB1*08:01 allele
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: G6PDH deficiency
Number of subjects: 182

Group type: COMPARATOR
Intervention: Influenza vaccination status
Number of subjects: 182
Study: 35577511

Group type: EXPERIMENTAL
Intervention: PB/TURSO
Number of subjects: 135

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study: 33524131

Group type: EXPERIMENTAL
Intervention: Gluten-Free Diet (GFD)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Gluten-Containing Diet (GCD)
Number of subjects: 51
Study: 32717341

Group type: EXPERIMENTAL
Intervention: Changes in visual acuity (VA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Implant placement in at least 1 eye
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cataract surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quieting of all eyes active at the beginning of the interval
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reductions in visual acuity (VA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Infections requiring a prescription
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Incident uveitis activity in at least 1 eye
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hospitalization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitreous hemorrhage in at least 1 eye
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Declines in visual acuity (VA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Initiation in IOP medication
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 0
Study: 33557924

Group type: EXPERIMENTAL
Intervention: Narrative enhancement and cognitive therapy (NECT)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: NECT
Number of subjects: 120
Study: 32126028

Group type: EXPERIMENTAL
Intervention: Phacoemulsification without ophthalmic viscosurgical devices (OVDs), using continuous irrigation mode and chopping technique.
Number of subjects: 0
Study: 35397367

Group type: EXPERIMENTAL
Intervention: soy milk + PS (1.6 g/day)
Number of subjects: 38

Group type: COMPARATOR
Intervention: soy milk (Control phase)
Number of subjects: 38
Study: 33113535

Group type: EXPERIMENTAL
Intervention: LI-guided therapy
Number of subjects: 290

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 290
Study: 32978540

Group type: EXPERIMENTAL
Intervention: Written information (a take‐home leaflet) on orthodontic pain characteristics and management
Number of subjects: 60

Group type: COMPARATOR
Intervention: General verbal instructions on orthodontic treatment
Number of subjects: 60
Study: 35467599

Group type: EXPERIMENTAL
Intervention: Facebook plus Health Professionals (FB+HP)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Facebook (FB)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 300
Study: 33838870

Group type: EXPERIMENTAL
Intervention: Insulin (20–40 mU/m2 per minute) and lipid (Intralipid) infusion
Number of subjects: 15

Group type: COMPARATOR
Intervention: Saline infusion (control)
Number of subjects: 15
Study: 34170931

Group type: EXPERIMENTAL
Intervention: Behavioural support group session
Number of subjects: 9056

Group type: COMPARATOR
Intervention: Control (no behavioural support group session)
Number of subjects: 9056
Study: 32826008

Group type: EXPERIMENTAL
Intervention: Combined procedure (passive cervical mobilization, active cervical rotation range of motion exercises, and stretching procedures)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Standard procedure (passive cervical mobilization and active cervical rotation range of motion exercise)
Number of subjects: 38
Study: 34333391

Group type: EXPERIMENTAL
Intervention: Milk and rapeseed protein (35 g per day, ratio 54:46 or 30:70)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Milk protein alone (35 g per day)
Number of subjects: 129
Study: 32067218

Group type: EXPERIMENTAL
Intervention: Metformin therapy for 6 months
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (women with PCOS without metformin)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Metformin therapy
Number of subjects: 90
Study: 35608580

Group type: EXPERIMENTAL
Intervention: Metformin 850 mg orally twice a day (n = 1824)
Number of subjects: 3649

Group type: COMPARATOR
Intervention: Placebo orally twice a day (n = 1825)
Number of subjects: 3649
Study: 33844368

Group type: EXPERIMENTAL
Intervention: Emollient bathing product (AFLOAT VET)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 2% miconazole/2% chlorhexidine shampoo (2% MIC/CHX)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (healthy dogs)
Number of subjects: 16
Study: 32130058

Group type: EXPERIMENTAL
Intervention: Sinetrol‐XPur (450 mg per tablet, 2 tablets once a day)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (2 tablets once a day)
Number of subjects: 100
Study: 36014789

Group type: EXPERIMENTAL
Intervention: 150 mg sodium butyrate twice a day (group A)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo (group B)
Number of subjects: 72
Study: 32409838

Group type: EXPERIMENTAL
Intervention: Cefazolin added to anesthetics (Group G)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional drug group (Group C)
Number of subjects: 0
Study: 34327667

Group type: EXPERIMENTAL
Intervention: Functional and visual identification of EBSLN
Number of subjects: 278

Group type: COMPARATOR
Intervention: No identification of EBSLN
Number of subjects: 278
Study: 34341520

Group type: EXPERIMENTAL
Intervention: Vosoritide (15.0 μg/kg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vosoritide (15.0 μg/kg/day) after crossover from placebo
Number of subjects: 0
Study: 36147434

Group type: EXPERIMENTAL
Intervention: CDC recommended guidelines for peripheral intravascular catheter insertion (Group 1)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard defined steps during insertion (Group 2)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Insertion at wrist joint
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Insertions during 0–24 h
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Insertions during 25–48 h
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Insertions at 72 h
Number of subjects: 200